Pharmaceutical form
Eye drops 2.5 mL.
Composition
1 mL contains 0.05 mg of latanoprost.
Product characteristics
The first-line drug for the treatment of glaucoma. Prostaglandin F2α analogue. It lowers intraocular pressure by increasing the aqueous humour outflow. Hypotensive action lasts for at least 24 hours.
Posology and method of administration
Instil 1 drop to the affected eye(s) once daily.
Therapeutic indications
To lower elevated intraocular pressure in patients with open-angle glaucoma and elevated intraocular pressure. To lower elevated intraocular pressure in pediatric patients with elevated intraocular pressure and childhood glaucoma.
Download instruction: LaproNext.pdf
